Research and Development Costs

RECENT NEWS
newratings.com  Feb 23  Comment 
AIXTRON SE: Financial targets achieved in 2016 / Positive net income in Q4/2016 / Full year negative due to ongoing high research and development costs / Order Intake and Equipment Order Backlog increase significantly DGAP-News: AIXTRON SE / Key...
Forbes  Jul 25  Comment 
Gilead has become the whipping boy du jour for the forthcoming Obamacare-driven cost explosion in health spending. Politicians and the health-insurance industry have embarked on a high-profile campaign to shame Gilead for the price of its new...




 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki